PSMB5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.90114632106997E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.96109947462276E-10 |
Normal-vs-Stage2 |
4.84057238736568E-14 |
Normal-vs-Stage3 |
1.23869803303478E-11 |
Normal-vs-Stage4 |
2.577500E-04 |
Stage1-vs-Stage2 |
3.806300E-04 |
Stage1-vs-Stage3 |
2.302400E-02 |
Stage1-vs-Stage4 |
8.670400E-01 |
Stage2-vs-Stage3 |
2.661200E-01 |
Stage2-vs-Stage4 |
1.343970E-02 |
Stage3-vs-Stage4 |
1.068820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.27276008913213E-14 |
Normal-vs-AfricanAmerican |
4.506200E-02 |
Normal-vs-Asian |
3.456500E-02 |
Caucasian-vs-AfricanAmerican |
2.023000E-03 |
Caucasian-vs-Asian |
1.807010E-01 |
AfricanAmerican-vs-Asian |
3.968400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.65545355201857E-12 |
Normal-vs-Female |
1.16529999982795E-07 |
Male-vs-Female |
2.072100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.41310000000228E-05 |
Normal-vs-Age(41-60Yrs) |
3.20700133116247E-11 |
Normal-vs-Age(61-80Yrs) |
3.89119847454822E-11 |
Normal-vs-Age(81-100Yrs) |
4.74860000210242E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.635400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.565400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.763770E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.848000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.950630E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.362470E-02 |
Normal-vs-Grade 2 |
1.16169962538493E-10 |
Normal-vs-Grade 3 |
1.18309806396155E-11 |
Normal-vs-Grade 4 |
3.93950000000531E-05 |
Grade 1-vs-Grade 2 |
3.525600E-01 |
Grade 1-vs-Grade 3 |
8.227900E-02 |
Grade 1-vs-Grade 4 |
3.063200E-01 |
Grade 2-vs-Grade 3 |
2.874600E-01 |
Grade 2-vs-Grade 4 |
9.552400E-01 |
Grade 3-vs-Grade 4 |
5.536800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.65878422109245E-12 |
Normal-vs-ccB subtype |
2.02700078943963E-11 |
ccA subtype-vs-ccB subtype |
5.597400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.23500099036278E-11 |
Normal-vs-N1 |
1.82590000008531E-07 |
N0-vs-N1 |
2.745000E-01 |
|
|